Cambridge Investment Research Advisors
NHS

Cambridge Investment Research Advisors’s Neuberger High Yield Strategies Fund Inc NHS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NHS Stock Details NHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Buy
+10,595
New +$77.7K ﹤0.01% 3825

Other funds holding NHS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
GA
GraniteShares Advisors New York $139M AUM 0.56% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cambridge Investment Research Advisors's NHS Position: Q1 2026 in Review

Cambridge Investment Research Advisors opened a new position in Neuberger High Yield Strategies Fund Inc (NHS) in Q1 2026: 10,595 shares worth $69K. The stake represents ﹤0.01% of the portfolio and ranks #3825 among its holdings.

53 funds tracked by Wall St. Rank hold NHS as of Q1 2026.

  • Cambridge Investment Research Advisors held 10,595 shares of Neuberger High Yield Strategies Fund Inc worth $69K as of Q1 2026.
  • Neuberger High Yield Strategies Fund Inc was a new Cambridge Investment Research Advisors position in Q1 2026.
  • Neuberger High Yield Strategies Fund Inc made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3825 holding.
  • 53 funds tracked by Wall St. Rank held Neuberger High Yield Strategies Fund Inc as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.